Table 1.

Baseline Patient and HCT Characteristics

Characteristic	N=200, (%)
Age	56.7 (19–73)
≥ 60	80 (40)
Sex (male)	104 (52)
Disease
AML	76 (38)
ALL	17 (9)
Acute Leukemia	3 (2)
MDS	47 (24)
MM	31 (16)
CLL/T-PLL	2 (1)
CML	10 (5)
MPD	9 (5)
NHL	4 (2)
FHLH	1 (1)
Regimen
Bu/Mel/Flu	131 (66)
Clo/Mel/Thio	13 (7)
TBI/Thio/CY	55 (28)
TBI/Thio/Flu	1 (1)
HLA
MRD	76 (38)
MMRD	1 (1)
MURD	78 (39)
MMURD	45 (23)

AML, acute myeloid leuekemia, ALL, acute lymphocytic leukemia; MDS, myelodysplastic syndrome; MM, multiple myeloma; CLL, chronic lymphocytic leukemia; T-PLL, T-prolymphocytic leukemia; CML, chronic myeloid leukemia; MPD, myeloproliferative disorder; NHL, non-Hodgkin lymphoma; FHLH, familial hemophagocytic lymphohistiocytosis; Bu, busulfan; Mel, melphalan; Flu, fludarabine; Clo, clofarabine; Thio, thiotepa; TBI, total-body irradiation; Cy, cyclophosphamide; HLA, human-leukocyte antigen; MRD, matched related donor; MMRD, mismatched-related donor; MURD, matched-unrelated donor; MMURD, mismatched unrelated donor.